Cutler Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$1K | – | 4405 |
|
|
2023
Q1 | $1K | Buy |
+1,000
| New | +$21.9K | ﹤0.01% | 3657 |
|
|
2022
Q4 | – | Sell |
-20,000
| Closed | -$10K | – | 5531 |
|
|
2022
Q3 | $10K | Buy |
+20,000
| New | +$263K | ﹤0.01% | 3168 |
|
|
2021
Q4 | – | Sell |
-27,000
| Closed | -$2K | – | 6399 |
|
|
2021
Q3 | $2K | Buy |
+27,000
| New | +$294K | ﹤0.01% | 5168 |
|
|
2019
Q1 | – | Sell |
-3,000
| Closed | -$11K | – | 4952 |
|
|
2018
Q4 | $11K | Hold |
3,000
| – | – | ﹤0.01% | 2497 |
|
|
2018
Q3 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 2747 |
|
|
2018
Q2 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 2770 |
|
|
2018
Q1 | $7K | Sell |
3,000
-2,000
| -40% | -$5.8K | ﹤0.01% | 3092 |
|
|
2017
Q4 | $9K | Hold |
5,000
| – | – | ﹤0.01% | 3256 |
|
|
2017
Q3 | $11K | Buy |
5,000
+200
| +4% | +$540 | ﹤0.01% | 3760 |
|
|
2017
Q2 | $13K | Sell |
4,800
-5,900
| -55% | -$16.1K | ﹤0.01% | 3917 |
|
|
2017
Q1 | $68K | Sell |
10,700
-110,000
| -91% | -$465K | ﹤0.01% | 2096 |
|
|
2016
Q4 | $862K | Buy |
120,700
+40,900
| +51% | +$1.21M | 0.03% | 463 |
|
|
2016
Q3 | $1.01M | Buy |
79,800
+56,300
| +240% | +$3.17M | 0.05% | 327 |
|
|
2016
Q2 | $106K | Buy |
23,500
+20,900
| +804% | +$1.04M | 0.01% | 1639 |
|
|
2016
Q1 | $27K | Buy |
2,600
+1,300
| +100% | +$66.2K | ﹤0.01% | 2981 |
|
|
2015
Q4 | $1K | Buy |
+1,300
| New | +$75.2K | ﹤0.01% | 6163 |
|
Cutler Group's ISEE Position: Q2 2023 in Review
Cutler Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 300 shares — an estimated $10.6K sold.
Cutler Group first reported a position in ISEE in Q4 2015 and held it in 21 quarters. The position peaked at $1.27M in Q3 2016. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Cutler Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Cutler Group sold 300 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $10.6K.
- Cutler Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 21 quarters.
- Cutler Group's IVERIC bio, Inc. Common Stock position peaked at $1.27M in Q3 2016.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.